Resumen

CORONADO, L.; ITURRIAGA, V.; BORNHARDT, T.  y  FUENTES, R.. Application protocol of hyaluronic acid on temporomandibular joint degenerative diseases. Av Odontoestomatol [online]. 2015, vol.31, n.2, pp.77-84. ISSN 2340-3152.  https://dx.doi.org/10.4321/S0213-12852015000200004.

Temporomandibular disorders are a heterogeneous group of functional disorders affecting the masticatory system, reducing the quality of life of patients. Within these disorders find the disc condyle complex disorders, which are risk factors for the generation of degenerative joint diseases of the temporomandibular joint (TMJ). The treatment of joint degenerative processes is controversial, and have been used over time varied therapeutic strategies, since the use of mandibular orthopedic devices, through invasive therapies such as arthrocentesis or irrigation and drainage of the joint spaces; drugs to infiltration into the joint space. Traditionally the intra infiltration articular drug was performed with glucocorticoids due to its anti-inflammatory and analgesic effect, however more than two decades ago has emerged using the hyaluronic acid, the inflammatory and viscosupplementation effect has demonstrated great therapeutic usefulness in degenerative processes articular level. Clinically this drug however lacks a protocol that regulates the therapeutic regimen in strength, dosage, frequency and extent of treatment in use in bone degenerative diseases of the TMJ. Thus arises the need to review the existing evidence on this in experimental studies in humans or animals. A review of the evidence was made available online, which after a process of analysis and selection scored 11 studies in humans and 4 in animals, the authors found insufficient evidence to establish a protocol infiltration of hyaluronic acid in degenerative pathologies temporo mandibular joint.

Palabras clave : Osteoarthritis; temporomandibular joint; hialuronic acid.

        · resumen en Español     · texto en Español     · Español ( pdf )